Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $238.9M | -- | -- | $0.22 | -- |
| 10/29/2025 | Q3 | $261.9M | $276.9M | $0.10 | $0.29 | -$0.19 |
| 07/30/2025 | Q2 | $246.1M | $249.1M | $0.24 | $0.24 | $0.00 |
| 04/30/2025 | Q1 | $212.3M | $216M | $0.14 | $0.13 | $0.01 |
| 02/12/2025 | Q4 | $220.7M | $229.7M | $0.16 | $0.16 | $0.01 |
| 10/30/2024 | Q3 | $231.8M | $234.7M | $0.17 | $0.19 | -$0.02 |
| 07/31/2024 | Q2 | $239.9M | $239.3M | $0.21 | $0.21 | $0.00 |
| 05/02/2024 | Q1 | $200.4M | $210.8M | $0.07 | $0.08 | -$0.01 |
| 02/15/2024 | Q4 | $188.2M | $196.7M | $0.07 | $0.09 | -$0.03 |
| 10/31/2023 | Q3 | -- | $197.2M | $0.11 | -- | -- |
| 08/03/2023 | Q2 | -- | $242.5M | $0.33 | -- | -- |
| 05/04/2023 | Q1 | -- | $201.1M | $0.15 | -- | -- |
| 02/16/2023 | Q4 | -- | $239.4M | $0.32 | -- | -- |
| 11/02/2022 | Q3 | -- | $209.6M | $0.19 | -- | -- |
| 08/02/2022 | Q2 | -- | $274.6M | $0.34 | -- | -- |
| 05/05/2022 | Q1 | -- | $282.4M | $0.38 | -- | -- |
| 02/17/2022 | Q4 | -- | $244.1M | $0.30 | -- | -- |
| 11/04/2021 | Q3 | -- | $284.8M | $0.44 | -- | -- |
| 08/05/2021 | Q2 | -- | $269.2M | $0.43 | -- | -- |
| 05/06/2021 | Q1 | -- | $239M | $0.39 | -- | -- |
| 02/11/2021 | Q4 | -- | $223.6M | $0.39 | -- | -- |
| 10/28/2020 | Q3 | -- | $251.1M | $0.49 | -- | -- |
| 07/29/2020 | Q2 | -- | $169.1M | -$0.01 | -- | -- |
| 04/27/2020 | Q1 | -- | $167.2M | $0.12 | -- | -- |
| 02/13/2020 | Q4 | -- | $169.8M | $0.46 | -- | -- |
| 10/28/2019 | Q3 | -- | $183.3M | $0.24 | -- | -- |
| 07/29/2019 | Q2 | -- | $199M | $0.28 | -- | -- |
| 04/29/2019 | Q1 | -- | $173.5M | $0.19 | -- | -- |
| 02/14/2019 | Q4 | -- | $193.3M | $0.26 | -- | -- |
| 10/29/2018 | Q3 | -- | $232.2M | $0.45 | -- | -- |
| 07/30/2018 | Q2 | -- | $211.3M | $0.32 | -- | -- |
| 04/30/2018 | Q1 | -- | $169.6M | $0.21 | -- | -- |
| 02/15/2018 | Q4 | -- | $182.9M | -$0.16 | -- | -- |
| 10/31/2017 | Q3 | -- | $266M | $0.57 | -- | -- |
| 07/31/2017 | Q2 | -- | $178.1M | $0.31 | -- | -- |
| 05/01/2017 | Q1 | -- | $139.1M | $0.26 | -- | -- |
| 02/16/2017 | Q4 | -- | $129.3M | $0.22 | -- | -- |
| 10/31/2016 | Q3 | -- | $148.2M | $0.31 | -- | -- |
| 08/01/2016 | Q2 | -- | $147.5M | $0.25 | -- | -- |
| 05/02/2016 | Q1 | -- | $96.2M | $0.09 | -- | -- |
| 02/10/2016 | Q4 | -- | $97.7M | -$0.16 | -- | -- |
Cognex Corp. reported $276.9M worth of top line sales in its most recent quarter.
Cognex Corp. announced earnings per share of $0.10 which represents a miss of analyst forecast a $0.29 per share.
Cognex Corp. reported $187.3M that represents $1.11 per share over the last quarter.
Cognex Corp.'s earnings are forecast to grow from $0.62 per share to $0.69 per share next year representing an increase of 56.54%.
Cognex Corp.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.